Paradigm Biopharmaceuticals Ltd at JPMorgan Healthcare Conference (Virtual) Transcript
Well, good morning and good afternoon, everyone. Welcome to the Paradigm Biopharmaceutical presentation. By way of background and introduction, my name is Seth Schwartz; I'm the Managing Director and Head of JPMorgan's Healthcare Investment Banking practice here in Australia. It gives me great honor to introduce Donna Skerrett, who is the Interim CEO of Paradigm and will lead today's presentation.
So with that, over to you, Donna.
Thank you. Can I have the next slide, please? Paradigm is a publicly traded company. So please note the disclaimer. Thank you. Next slide.
I'd like to tell you a little bit about Paradigm. We're an Australian company founded in 2014, listed on the Exchange in 2015. And our objective is to repurpose agents, and we aim to develop new solutions for medical indications with high unmet need by repurposing underutilized molecules.
Our lead candidate is
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |